Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staphylococcus and Neisseria Tablets in COPD
NCT05975788Phase 4Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Nov 2023
- Primary completion
- Feb 2025
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of staphylococcus albus + neisseria catarrhalis in chronic obstructive pulmonary disease (COPD), sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
staphylococcus albus + neisseria catarrhalis
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05975788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05975788.